CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Retained Earnings
Beginning balance at May. 02, 2020	$ 783.4	$ 19.2	$ 150.7	$ (26.9)	$ (11.5)	$ 651.9
Beginning balance (in shares) at May. 02, 2020		38,438,111
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding	(3.9)	$ 0.7	(0.7)			(3.9)
Issuance of restricted stock, net of tax withholding (in shares)		1,350,251
Exercise of stock options	0.1		0.1
Exercise of Stock Options (in shares)		5,000
Stock-based compensation expense	4.3		4.3
Other comprehensive income (loss)	35.1			35.1
Net income	91.2					91.2
Dividends on common stock	(12.6)					(12.6)
Ending balance at Jan. 30, 2021	897.6	$ 19.9	154.4	8.2	(11.5)	726.6
Ending balance (in shares) at Jan. 30, 2021		39,793,362
Beginning balance at Oct. 31, 2020	851.4	$ 19.4	152.5	(7.9)	(11.5)	698.9
Beginning balance (in shares) at Oct. 31, 2020		38,876,362
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding		$ 0.5	(0.5)
Issuance of restricted stock, net of tax withholding (in shares)		917,000
Stock-based compensation expense	2.4		2.4
Other comprehensive income (loss)	16.1			16.1
Net income	31.9					31.9
Dividends on common stock	(4.2)					(4.2)
Ending balance at Jan. 30, 2021	897.6	$ 19.9	154.4	8.2	(11.5)	726.6
Ending balance (in shares) at Jan. 30, 2021		39,793,362
Beginning balance at May. 01, 2021	918.0	$ 19.8	157.6	6.1	(11.5)	746.0
Beginning balance (in shares) at May. 01, 2021		39,644,913
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding	(0.3)	$ 0.1	(0.1)			(0.3)
Issuance of restricted stock, net of tax withholding (in shares)		44,245
Exercise of stock options	0.5		0.5
Exercise of Stock Options (in shares)		13,000
Purchases of common stock	$ (63.7)	$ (0.7)				(63.0)
Purchases of common stock (in shares)	(1,425,190)	(1,425,190)
Stock-based compensation expense	$ 8.4		8.4
Other comprehensive income (loss)	(16.7)			(16.7)
Net income	86.0					86.0
Dividends on common stock	(15.8)					(15.8)
Ending balance at Jan. 29, 2022	916.4	$ 19.2	166.4	(10.6)	(11.5)	752.9
Ending balance (in shares) at Jan. 29, 2022		38,276,968
Beginning balance at Oct. 30, 2021	919.5	$ 19.4	163.8	(2.0)	(11.5)	749.8
Beginning balance (in shares) at Oct. 30, 2021		38,737,129
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Purchases of common stock	$ (21.3)	$ (0.2)				(21.1)
Purchases of common stock (in shares)	(460,161)	(460,161)
Stock-based compensation expense	$ 2.6		2.6
Other comprehensive income (loss)	(8.6)			(8.6)
Net income	29.4					29.4
Dividends on common stock	(5.2)					(5.2)
Ending balance at Jan. 29, 2022	$ 916.4	$ 19.2	$ 166.4	$ (10.6)	$ (11.5)	$ 752.9
Ending balance (in shares) at Jan. 29, 2022		38,276,968